Reactivation of latent viral hepatitis infection in patients of chronic myeloid leukemia treated with imatinib mesylate: Experience from a tertiary cancer center in India.

被引：0
|
作者：
Ostwal, V. [1 ]
Ghadyalpatil, N. [1 ]
Prabhash, K. [1 ]
Menon, H. [1 ]
Nair, R. [1 ]
Sengar, M. [1 ]
Noronha, V. [1 ]
Biswas, S. [1 ]
Bhosale, B. [1 ]
Banavali, S. [1 ]
机构：
[1] Tata Mem Hosp, Bombay 400012, Maharashtra, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6593
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6593
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Imatinib mesylate experience of young patients with chronic myeloid leukemia in chronic phase-Care to cure
    Biswajit, D.
    Rejiv, R.
    Manjunath, N.
    Prasad, G.
    Lakshmi, S.
    Devika, P.
    Geetha, K.
    Sagar, T. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Occurence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate.
    Schoch, C
    Haferlach, T
    Kern, W
    Schnittger, S
    Schneller, F
    Berger, U
    Hehlmann, R
    Hiddemann, W
    Hochhaus, A
    BLOOD, 2002, 100 (11) : 364A - 365A
  • [33] Predictors of Treatment Non-Adherence in Patients Treated with Imatinib Mesylate for Chronic Myeloid Leukemia
    StCharles, Meaghan
    Bollu, Vamsi K.
    Hornyak, Elizabeth
    Coombs, John
    Blanchette, Christopher M.
    DeAngelo, Daniel J.
    BLOOD, 2009, 114 (22) : 870 - 870
  • [34] Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country
    Iqbal, Javaid
    Ali, Zafar
    Khan, Aruj-un-Nisa
    Aziz, Zeba
    LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 2109 - 2113
  • [35] MULTICENTER EXPERIENCE WITH IMATINIB MESYLATE IN 202 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
    Carella, A. M.
    Orlandi, E.
    Lazzarino, M.
    Annunziata, M.
    Ferrara, F.
    Pungolino, E.
    Morra, E.
    Barate, C.
    Petrini, M.
    Miglino, M.
    Gobbi, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 222 - 222
  • [36] Multicenter experience with imatinib mesylate in 202 newly diagnosed chronic myeloid leukemia (CML) patients
    Carella, M.
    Orlandi, E.
    Lazzarino, M.
    Annunziata, M.
    Ferrara, F.
    Pungolino, E.
    Morra, E.
    Barate, C.
    Petrini, M.
    Miglino, M.
    Gobbi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] High Incidence of Hepatitis B Viral Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
    Uhm, Jieun
    Kim, Sung-Hyun
    Oh, Sukjoong
    Zang, Dae Young
    Do, Young Rok
    Lee, Won Sik
    Chang, Myung Hee
    Lee, Sung-Eun
    Kim, Dong-Wook
    BLOOD, 2018, 132
  • [38] The efficacy of generic imatinib in patients with chronic myeloid leukemia - a single center experience
    Urosevic, Ivana
    Percic, Ivanka
    Jojkic, Marina Dragicevic
    Dokic, Marina
    El Farra, Amir
    Savic, Aleksandar
    Milosevic, Ivana
    Vlaisavljevic, Nada
    Sekulic, Borivoj
    Balint, Bela
    VOJNOSANITETSKI PREGLED, 2021, 78 (05) : 526 - 531
  • [39] Tuberculosis infection in chronic myeloid leukemia (CML) patients treated with imatinib.
    Ghadyalpatil, N.
    Prabhash, K.
    Menon, H.
    Nair, R.
    Banavali, S.
    Noronha, V.
    Wabale, V.
    Singh, R.
    Goyal, G.
    Ostwal, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate
    Atagunduz, Isik Kaygusuz
    Toptas, Tayfur
    Deniz, Rabia
    Kara, Osman
    Eser, All
    Sezgin, Aslihan
    Ozgumus, Toluy
    Gecgel, Fatma
    Tuglularl, Tulin Firatli
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (02): : 120 - 125
12345